Literature DB >> 6171519

Interferon induction in primates by stabilized polyriboinosinic acid-polyribocytidylic acid: effect of component size.

H B Levy, F L Riley, E Lvovsky, E E Stephen.   

Abstract

Two series of interferon-inducing complexes containing polyriboinosinic and polyribocytidylic acids, poly-L-lysine, and carboxymethyl cellulose were prepared. One series contained carboxymethyl cellulose, 27,000-molecular-weight poly-L-lysine, and either 4S, 6S, or 9S polyriboinosinic and polyribocytidylic acids. The other series contained carboxymethyl cellulose, 9S polyriboinosinic and polyribocytidylic acids, and poly-L-lysine, whose molecular weights ranged from 2,000 to 27,000. The homogeneity of these double-stranded polynucleotide complexes was confirmed by single-step thermal denaturation profiles and by single peaks in sucrose gradient velocity sedimentation. The complexes have a greater resistance to hydrolysis by ribonuclease than does polyriboinosinic-polyribocytidylic acid. The resistance to ribonuclease increased with the increasing size of polynucleotide homopolymers and poly-L-lysine. In monkeys and, to a lesser extent, in mice, serum interferon levels induced by the different complexes were related to the degree of resistance of the complexes to hydrolysis by ribonuclease. In mice, 4S, 6S, and 9S complexes of polyriboinosinic-polyribocytidylic acid, poly-L-lysine, and carboxymethyl cellulose had a higher level of toxicity than did polyriboinosinic-polyribocytidylic acid as measured by 50% lethal dose. The toxicity was parallel to the ribonuclease resistance of the complexes. It was concluded that an increase in the size of the polynucleotides and the polyamino acids in these complexes leads to higher resistance to hydrolysis by ribonuclease and to greater interferon responses in mice and rhesus monkeys.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171519      PMCID: PMC350882          DOI: 10.1128/iai.34.2.416-421.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  5 in total

1.  The interaction of polynucleotides with cations.

Authors:  G FELSENFELD; S HUANG
Journal:  Biochim Biophys Acta       Date:  1959-07

2.  Inhibition of biologic activity of poly I: poly C by human plasma.

Authors:  J J Nordlund; S M Wolff; H B Levy
Journal:  Proc Soc Exp Biol Med       Date:  1970-02

3.  Interaction of poly-L-lysine and nucleic acids.

Authors:  M Tsuboi; K Matsuo; P O Ts'o
Journal:  J Mol Biol       Date:  1966-01       Impact factor: 5.469

4.  A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates.

Authors:  H B Levy; G Baer; S Baron; C E Buckler; C J Gibbs; M J Iadarola; W T London; J Rice
Journal:  J Infect Dis       Date:  1975-10       Impact factor: 5.226

5.  A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors.

Authors:  R A Robinson; V T DeVita; H B Levy; S Baron; S P Hubbard; A S Levine
Journal:  J Natl Cancer Inst       Date:  1976-09       Impact factor: 13.506

  5 in total
  5 in total

1.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

Authors:  Lis R V Antonelli; Antonio Gigliotti Rothfuchs; Ricardo Gonçalves; Ester Roffê; Allen W Cheever; Andre Bafica; Andres M Salazar; Carl G Feng; Alan Sher
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

2.  Evaluation of [(11)C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infection.

Authors:  Chie Seki; Arata Oh-Nishi; Yuji Nagai; Takafumi Minamimoto; Shigeru Obayashi; Makoto Higuchi; Makoto Takei; Kenji Furutsuka; Takehito Ito; Ming-Rong Zhang; Hiroshi Ito; Mototsugu Ito; Sumito Ito; Hiroyuki Kusuhara; Yuichi Sugiyama; Tetsuya Suhara
Journal:  EJNMMI Res       Date:  2014-07-02       Impact factor: 3.138

Review 3.  Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.

Authors:  Andri Vasou; Nazife Sultanoglu; Stephen Goodbourn; Richard E Randall; Leondios G Kostrikis
Journal:  Viruses       Date:  2017-07-13       Impact factor: 5.048

4.  Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.

Authors:  Edward Sionov; Katrin D Mayer-Barber; Yun C Chang; Keith D Kauffman; Michael A Eckhaus; Andres M Salazar; Daniel L Barber; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2015-08-07       Impact factor: 6.823

5.  Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.

Authors:  Seyedmojtaba Seyedmousavi; Michael J Davis; Janyce A Sugui; Tzvia Pinkhasov; Shannon Moyer; Andres M Salazar; Yun C Chang; Kyung J Kwon-Chung
Journal:  MBio       Date:  2018-03-27       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.